5 Genomics Stocks Cathie Wood is buying in 2026 (And the 1 giant she’s reducing)

Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling off Tesla, Roku, and Shopify. She believes 2026 will mark the breakthrough moment when AI-powered genomics moves from lab curiosity to commercial reality, but it's a high-risk gamble on early-stage biotech companies that could take years to pay off.